These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10952427)

  • 1. Animal models of hypertrophic cardiomyopathy.
    Maass A; Leinwand LA
    Curr Opin Cardiol; 2000 May; 15(3):189-96. PubMed ID: 10952427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of transgenic animal in hypertrophic cardiomyopathy].
    Ma ZF; Liu WL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):666-9. PubMed ID: 18087565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.
    Tardiff JC
    Heart Fail Rev; 2005 Sep; 10(3):237-48. PubMed ID: 16416046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
    Redwood CS; Moolman-Smook JC; Watkins H
    Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genotype-phenotype correlations in familial hypertrophic cardiomyopathy].
    Anan R; Niimura H; Tei C
    Nihon Rinsho; 2000 Jan; 58(1):134-40. PubMed ID: 10885301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
    Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
    J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextrocardia and symmetric hypertrophic cardiomyopathy with multiple mutations of genes encoding the sarcomere proteins.
    Fang F; Cui FM; He YM; Yang XJ; Zhao X; Xu HF; Yu CM
    Int J Cardiol; 2015; 187():581-4. PubMed ID: 25863306
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
    Thierfelder L; Watkins H; MacRae C; Lamas R; McKenna W; Vosberg HP; Seidman JG; Seidman CE
    Cell; 1994 Jun; 77(5):701-12. PubMed ID: 8205619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of familial hypertrophic cardiomyopathy (FHC).
    Bashyam MD; Savithri GR; Kumar MS; Narasimhan C; Nallari P
    J Hum Genet; 2003; 48(2):55-64. PubMed ID: 12601548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic variation and targeted therapy of hypertrophic cardiomyopathy using genetic animal models.
    Gannon MP; Link MS
    Trends Cardiovasc Med; 2021 Jan; 31(1):20-31. PubMed ID: 31862214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRET-based analysis of the cardiac troponin T linker region reveals the structural basis of the hypertrophic cardiomyopathy-causing Δ160E mutation.
    Abdullah S; Lynn ML; McConnell MT; Klass MM; Baldo AP; Schwartz SD; Tardiff JC
    J Biol Chem; 2019 Oct; 294(40):14634-14647. PubMed ID: 31387947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.
    Rice R; Guinto P; Dowell-Martino C; He H; Hoyer K; Krenz M; Robbins J; Ingwall JS; Tardiff JC
    J Mol Cell Cardiol; 2010 May; 48(5):979-88. PubMed ID: 20004663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.
    Van Driest SL; Ackerman MJ; Ommen SR; Shakur R; Will ML; Nishimura RA; Tajik AJ; Gersh BJ
    Circulation; 2002 Dec; 106(24):3085-90. PubMed ID: 12473556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypertrophic cardiomyopathy.
    Piano MR
    J Cardiovasc Nurs; 1999 Jul; 13(4):46-58. PubMed ID: 10386271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms regulating the myofilament response to Ca2+: implications of mutations causal for familial hypertrophic cardiomyopathy.
    Palmiter KA; Solaro RJ
    Basic Res Cardiol; 1997; 92 Suppl 1():63-74. PubMed ID: 9202846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.